We have examined HP1-chromatin interactions in different molecular contexts in vitro and in vivo. Employing purified components we show that HP1 exhibits selective, stoichiometric, and salt-resistant binding to recombinant histone H3, associating primarily with the helical "histone fold" domain. Furthermore, using "bulk" nucleosomes released by MNase digestion, S-phase extracts, and fragments of peripheral heterochromatin, we demonstrate that HP1 associates more tightly with destabilized or disrupted nucleosomes (H3/H4 subcomplexes) than with intact particles. Western blotting and mass spectrometry data indicate that HP1-selected H3/H4 particles and subparticles possess a complex pattern of posttranslational modifications but are not particularly enriched in me 3 K9-H3. Consistent with these results, mapping of HP1 and me 3 K9-H3 sites in vivo reveals overlapping, yet spatially distinct patterns, while transient transfection assays with synchronized cells show that stable incorporation of HP1-gfp into heterochromatin requires passage through the S-phase. The data amassed challenge the dogma that me 3 K9H3 is necessary and sufficient for HP1 binding and unveil a new mode of HP1-chromatin interactions.Histone modifications are thought to provide specific readouts that are selectively utilized in DNA transactions or chromatin state transitions (1). Given the multiplicity of modification sites and the diverse chemistries of post-translational modifications, the combinatorial repertoire of this putative "histone code" might have enormous dimensions; for instance, methylation of the five lysine residues that are located at the amino-terminal tail of histone H3 could yield alone over 15 ϫ 10 3 distinct patterns, while "saturation marking" of all lysines, arginines, serines, and threonines that are found in the same region would result in ϳ256 ϫ 10 6 combinations. Clearly then, even if 1% of the predicted patterns were materialized in vivo, this voluminous "instruction manual" could not be functionally interpreted without the aid of specific de-coding factors. Consistent with this idea, recent studies have identified a set of chromatin-associated proteins that bind specifically modified histones and could, at least in theory, fulfil such a de-coding role. As it turns out, these "effector" molecules are often components of large enzymatic assemblies and possess specialized modules known as bromo-, tudor-, or chromodomains (2).A classic example of a chromodomain-containing protein is HP1, a conserved constituent of eukaryotic cells, which, in metazoans, comprises three distinct variants: ␣, , and ␥ (3). HP1␣ and HP1 are localized in compact heterochromatic regions, while HP1␥ is more abundant in euchromatic territories (reviewed in Refs. 4 and 5). All HP1 variants have the same molecular architecture: they contain an amino-terminal chromodomain (CD), 5 an intervening region ("hinge") and a carboxylterminal chromoshadow domain (CSD). The CD is thought to be responsible for chromatin association, whereas the CSD rep...